Cita APA

Garner, E. F., Stafman, L. L., Williams, A. P., Aye, J. M., Goolsby, C., Atigadda, V. R., . . . Beierle, E. A. (2018). UAB30, a Novel RXR Agonist, Decreases Tumorigenesis and Leptomeningeal Disease in Group 3 Medulloblastoma Patient-Derived Xenografts. J Neurooncol.

Chicago Style Citation

Garner, Evan F., et al. "UAB30, a Novel RXR Agonist, Decreases Tumorigenesis and Leptomeningeal Disease in Group 3 Medulloblastoma Patient-Derived Xenografts." J Neurooncol 2018.

Cita MLA

Garner, Evan F., et al. "UAB30, a Novel RXR Agonist, Decreases Tumorigenesis and Leptomeningeal Disease in Group 3 Medulloblastoma Patient-Derived Xenografts." J Neurooncol 2018.